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IN VIVO SUPPRESSION OF
DELAYED HYPERSENSITIVITY : PROLONGATION OF
DESENSITIZATION IN GUINEA PIGS*
BY J . M. DWYER AND F. S. KANTOR
(From the Department ofInternal Medicine, Yale University School of Medicine, New Haven,
Connecticut 06510)
Effector mechanisms for delayed hypersensitivity (DH)' reactions have been
extensively studied but the control ofthese mechanisms remains poorly under-
stood(1). Several lines ofevidence favoractive regulation ofthe DH response (2).
We have been particularly interested in the possibility that the anergic states
seen in certain human diseases, such as sarcoidosis and Hodgkin's disease, may
represent an exaggeration ofa normal shutoffmechanism; i.e., anactive rather
than a passive process. In this report we present evidence that supports the
concept that DH responses can be actively suppressed in vivo by exaggerated
interaction between antigens and responding lymphocytes and that the anergy
induced can be prolonged.
We used desensitized guinea pigs for these experiments. The systemic admin-
istration of a single large dose (milligram) of antigen to guinea pigs 7-8 days
after immunization with that antigen resulted in loss of the normal DH skin
response (1, 3). When desensitization was produced by a single injection of
antigen the loss was transient, lasting 2-3 days (4). A most important detail of
this phenomenon is that during the period ofdesensitization the animal did not
express a DH response to heterologous antigens to which it had been success-
fully immunized, but not desensitized (1, 3). This non-specific desensitization
was also transient. Previously, we reported that this generalized suppression of
DH reactivity is not due to exhaustion of antigen or depletion of specifically
reactive lymphocytes and/or their lymphokines (1-4). Desensitization appears to
work via an active environmental factor(s); when we transferred competent
lymphocytes into desensitized guinea pigs these cells lost their competence (4).
Cells removedfrom desensitized animals regained their immunological reactiv-
ity (4). The experiments now described suggest that this active suppression can
be maintained only while antigen is capable of reacting with sensitized, non-
tolerant cells.
* Supported in part by grants no. AI-11785 and no. AI-11077 from the National Institutes of
Health.
'Abbreviations used in this paper: BGG, bovine gamma globulin; CFA, complete Freund's
adjuvant; DH, delayed hypersensitivity; FCS, fetal calf serum; FIF, feedback inhibition factor;
HSA, human serum albumin; OA, ovalbumin; PE, peritoneal exudate; Pic-GPA, picrylated
guinea pig albumin; PHA, phytohemagglutinin; PPD, purified protein derivative of tuberculin;
SRF, skin reactive factor.
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Materials and Methods
Animals.
￿
Hartley strain albino female guinea pigs weighing between 350 and 400 g or inbred
strain 2 guinea pigs weighing between400 and 550 gwere immunizedand used as donors of cells.
Younger guinea pigs weighing approximately 250 g were used as recipients in cell transfer
experiments.
Antigens.
￿
Picrylated guinea pig albumin (Pic-GPA), approximately 21 groups/mol was pre-
pared by modification ofthe method described by Eisen et al . (5) and detailed in previous reports
from this laboratory (6). Human serum albumin (HSA) was obtained from the American Red
Cross. Bovine gamma globulin (BGG)-fraction II was obtained from Schwarz/Mann Div., Becton,
Dickinson & Co., Orangeburg, N. Y.; ovalbumin (OA) from Worthington Biochemical Corp.,
Freehold, N. J. ; and a purified protein derivative of tuberculin (PPD) from Connaught Medical
Research Labs, Willowdale, Canada.
Immunization.
￿
Guinea pigs were immunizedby foot pad injection of 200 Ag antigen in 0.05ml
of saline emulsified in an equal volume ofcomplete Freund's adjuvant (CFA) (Difco Laboratories,
Detroit, Mich.). When multiple antigens were administered, the emulsions were pooled, mixed,
and an equal vol (0.1 ml) injected into each foot pad.
Desensitization.
￿
Animals to be desensitized were given a subcutaneous or intravenous injec-
tion of 2 mg of HSA and 2 mg of BGG commencing on the 7th or 8th day after immunization and
this was continued daily for time periods given with the results of individual experiments.
Skin Tests. Separate intradermal injections (0.1 ml) of each antigen were given in the
following amounts: Pic-GPA, 20 Wg; HSA, 25 wg; OA, 25 Ag; PPD, 25 Wg; andBGG, 50 lug, except
in one experiment detailed in the text where smaller doses of antigen were used. Skin reactions
were read at 24 h and the mean diameter of erythema and induration measured. To assess the
success ofdesensitization, intradermal challengewith allsensitizing antigens wasperformedonly
after at least two desensitizing injections of antigen and the reactions were compared with a
control group immunized, but notdesensitized. To detect any effect oflocally administered serum
from desensitized animalson DH responses in immunized animalsthenormal skin test dose of Pic-
GPA, PPD, and HSA were injected into one flank and an injection of an equal volume of fluid
containing the standard amount or half the standard amount ofantigen in 50%desensitized serum
was injected simultaneously into the otherflank.
Passive Transfer ofDH.
￿
Viable peritoneal exudate (PE) or spleen cells (150-250 x 106) were
obtained from immunized anddesensitized guinea pigs as follows: 3 days afterthe injection of 30
ml of mineral oil into the peritoneal cavity, PE cells were harvested by the injection into andthe
subsequent drainage from the peritoneal cavity of 100 ml of Hanks' buffered salt solution. When
splenectomy was performed, a single cell suspension was made by gently teasing the spleen
through a stainlesssteel sieve (80 gauge mesh) into aPetridish containing modified Eagle's media
(MEM) and 10% fetal calf serum (FCS). Both the peritoneal and spleen cells were centrifuged at
350 g for 10 min and the pellets washed twice. Cells from two or three animals were pooled to
provide 150-250 x 106 viable cells. After culture for 16 h in a 37°C CO2 incubator or after
immediate resuspension in a final vol of 2 ml of MEM containing 10% FCS, cells were drawn
through a25 gauge needle into asyringeand injected intravenously into therecipient guinea pigs.
Recipients were skin tested immediately after the cell transfer.
Hemagglutinating Antibody.
￿
Antibody levels to HSA and OA were measured by their ability
to agglutinate humanredblood cells coated with antigen. Human type "O"blood wasdefibrinated
and washed. Theredcells were removed, packed, andmixed at room temperature for4min with 3
ml of 0.1% of CrC13 (Mallinckrodt Chemical Works, St. Louis, Mo.) and 3 ml of HSA or OA at a
concentration of 10 mg/ml. The treated cells were washed five times and resuspended at 5%
concentration in saline. Finally, the red cellswere diluted 1:5 in phosphate-buffered saline (PBS).
The serum to be examined for antibody was tested at a dilution of 1:10 with PBS containing 1%
rabbit serum previously absorbed with human red blood cells. Hyperimmune antisera to OA and
HSA made in rabbits by Dr. Philip W. Askenase was used forcontrol purposes. IgGantibody was
measured by treating serum with mercaptoethanol (Pierce Chemical Co., Rockford, Ill.). To the
0.1 ml of serumto be tested wasadded 0.3 ml of 0.133 M mercaptoethanol; the mixturewas held at
room temperature for 2 h. Serial dilutions of serum were added to autotiter hemagglutination
plates containing treated red cells and the agglutination end point read. Forsimplicity, antibody
results areexpressedas the well number where agglutination ended on a scale of 1-15 where 1 is590 SUPPRESSION OF DELAYED HYPERSENSITIVITY
the well representing atiter of 1/10, and 15 a titer of 1/160,000.
Serum from Desensitized Animals.
￿
This serum for either in vitro or in vivo experiments was
obtained by immunizing guinea pigs as above, and selecting those animals whoexhibited thebest
generalized reduction in DH reactions. These animals were exsanguinated by cardiac puncture
and the serum recovered, pooled, and stored at -4°C after passage through a Millipore filter.
Cell Cultures.
￿
Experiments were performed in which either guinea pig or human cells were
stimulated in vitro with phytohemagglutinin (PHA-P) (Difco Laboratories), or PPD in avariety of
test sera. Blood was drawn into a heparinized syringe and spun for 45 min through a Ficoll-
Hypaque gradient (Pharmacia Laboratories, Piscataway, N. J .), and the lymphocyte layer re-
covered and washed three times in MEM containing penicillin and streptomycin. The cells were
brought to afinal concentration of 2-5 x 106/ml in MEM containing L-glutamine (Microbiological
Associates, Inc., Bethesda, Md.), penicillin and streptomycin, and 30% serum. Thetype of serum
is identified in each experiment. To 1 ml of cells in media was added 0.5 ml of media containing
1/400, 1/800, or 1/1,600 of the stock solution ofPHA-P. PPD stimulation wasachieved using 25 leg of
PPD for guinea pig cells and 100,ug PPD for human cells . PHA cultures were terminated at 72 h,
PPD cultures after 6 days, and in both cases cultures were pulsed with 1 .0 WCi of tritiated
thymidine (New England Nuclear, Boston, Mass.), for the 24 h before termination. All cultures
were performed in triplicate. Ourlaboratory's method for termination, harvesting, andscintilla-
tion counting have previously been described in detail (7). Theresults arereported as stimulation
indices with the mean value and standard deviation provided. The counts per minute from
unstimulated lymphocytes are also provided so that absolute increases in counts perminute canbe
calculated.
Results
Prolongation of Desensitization by Daily Injections of Antigens .
￿
18 guinea
pigs were immunized with HSA and BGG in CFA and 9 were desensitized with
dailyinjections of2 mg ofHSA and BGGfrom the 6thto 30th day postimmuniza-
tion. The antigens inducing desensitization (in this case, HSA and BGG), are
hereafter referred to as the desensitizing antigens while the antigen whose DH
effect they block (in this case, PPD) is referred to as the indifferent antigen. DH
skin reactions to HSA and PPD were sought in both the control group and the
desensitized animals seven times during the 30-day period and the intervalsand
results are shown in Fig. 1. Reducedresponses to the indifferent antigen (PPD)
could only be prolonged for 10 days by this regimen. Nonreactivity to the
desensitizing antigen (HSA) continued throughout.
Humoral Immune Response to Desensitizing and Indifferent Antigens .
￿
To
determine whether the repeated administration of antigen was inducing toler-
ance to that antigen, wemeasuredantibody levels to both a desensitizing and an
indifferent antigen during a 100 day period. 16 guinea pigs were immunized
with HSA and OA in CFA. From the 7th to the 36th postimmunization day,
eightwere desensitized daily with 1 mg ofHSA. Onthe45th day after immuniza-
tion all animals were reimmunized with HSA in CFA. Antibody to HSAand OA
was measured each week by hemagglutination techniques and the results are
shown in Table I. Inboth groups, antibody levels to OA (the indifferent antigen)
rose steadily and remained high for the full 100-day period. Throughout the
period of desensitization, even when DH responses to OA were markedly re-
duced, no significant suppression of either mercaptoethanol-sensitive or -resist-
ant antibody to OA was observed. In comparison, while control animals devel-
oped and maintained high titers of anti-HSA antibody, the desensitized group
exhibited an initial rise in HSA antibody and then a fall to very smalltiters and
even reimmunization with HSA in CFA didnotreverse thisphenomenon. OnsetE
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FIG. 1. 18 guinea pigs were immunized with PPD and HSA on day 0, and 9 were
immunizedwith dailyinjections of 1 mg ofHSA from day 6to day 30. DH reactionsto PPD
in the control guinea pigs are compared with DH reactions to PPD and HSA in the
desensitized guinea pigs. Note that both the HSA and PPD responses are affected by
desensitizationbutthat thePPDresponse returnsto normal about10 days afterdesensitiza-
tion commences.
ofthe fall in HSA antibody levels in the desensitized group was associated with
a return of DH to OA. These observations suggest that the establishment of
immunological tolerance to an antigen terminates the ability of desensitizing
amounts ofthat antigen to suppress DH responses to indifferent antigens.
Success of Desensitization Related to Degree of Immunization .
￿
In outbred
desensitized guinea pigs, the degree of nonspecific anergy induced by antigen
injection is variable. Comparison of the size of DH responses to immunogens
before desensitization and the subsequent production of desensitization demon-
strates that the better the DH responses before desensitization, the better the
nonspecific anergy after desensitization. 64 guinea pigs were immunized with
HSA andBGG in CFA. DH responsestoPPD, BGG, and HSA were measured on
the 6th day and after 2 days ofdesensitization with HSA and BGG. As is shown
inTable II, groupingthe 32 animals with the bestDHresponses before desensiti-
zation reveals that these animalsdevelop statisticallybetter (P < 0.001) desensi-
tization to both the desensitizing and indifferent antigens than the 32 animals
with inferior DH responses after immunization.
Prolongation of Tuberculin Anergy with Three Consecutive Desensitiz-
ing Regimens. If nonspecific anergy reverses when tolerance is induced (vide
supra), then immunization and subsequent desensitization with new antigens
should restore the nonspecific anergy. To test this hypothesis 24 guinea pigs
were immunized with HSA in CFA and desensitized with daily injections of
HSA from the 6th day to the 55th day after immunization. As shown in Fig. 2,
the DHskin response to HSAdiminished andremained minimal throughout. As
previously observed, the DH skin response to PPD, the indifferent antigen, fell
but returned after 10 days ofdesensitizationwith HSA. However, when animals592 SUPPRESSION OF DELAYED HYPERSENSITIVITY
A S
O W
ti M
￿
O
to
aD on
WW
00
oNcmte° m
- o o 0 0
h m o +I +I +I +I +I
C
d
A
o N to o to
v'ofa~M c~
C7
0
M m
O CO L~ V~ m
O N N O O O
o +I +I +I +I +I
O
U
N O O
m n N M tm .1
0 O
t7
O
n O to m
y to O N O O O O
m +I +I +I +I +I +I
U A
A
d; Ln - R c9 Lo
.-~ ~ of c~ .r ~a
+I -c
. d
q
ro
0
ti~r~rw co
m
A
m
s o .
q O +I +I +I +I +I 0
O
U
01 CN! er 'V'
t° O m M m
m ro
3
y
b 0 a ro
C d
.a
q C
00 0 0
0 0 .- A 0 v
A
ro v
d
o +I +I o +I O 00
q F A o ~° to y
ro N N ti ro
r-i d q 00
Pa a0
H t0 `d 00 N
'+ o 0 O
F ro
0
0 +I +I +I +I +I
N
0l)
ro
U H O
x d
y
x x N m o tc V
A
m
.-+ N O
0 +I +I +I +I +I 3
N
d
A
o N N o N
mtriom 0
ro
d .
C
ro
0 ,L1
0
'. m an to m 01 o o 0 7
+I +I +I +I +I +I
4q
0
U
L~ [: t -0 N N
ci~NCir~
;
m 3
td w a
of O
m m OA C
m m x . ro ro +I u co
.o o w ra', a> a aa)
d '° a ° m .3 at a a
a d
A N t~ ~ C) ro ro F7 ~ .~ m v
A a' o
t e a F A to
0 AAAG~~ v .cTABLE 11
Relationship of the Size ofDH Skin Reactions Elicited after Immunization to the
Subsequent Degree ofDesensitization
Group
￿
No.
of
￿
6 days after immunization'
￿
After 2 days desensitization$ animals
"Good" DH
￿
32
￿
14±3.2
￿
21±4.4
￿
25±6.1
￿
5±1.8
￿
4±1.2
￿
3±1.4
"Poorer" DH re-
￿
32
￿
11 ± 3.7
￿
15 ± 2.4
￿
11 ± 6.8
￿
10 ± 3.4
￿
9 ± 3.7
￿
10 ± 4.1
sponse afterim-
munization§
All animals immunized with BGG and HSA in CFA.
# 8 days after immunization with BGG and HSA in CFA and 2 days after desensitization.
§ Difference in skin test response between the two groups after desensitization are statistically
significant.
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FIG. 2. Animals consecutively immunized and desensitized with HSA, BGG, and OA
cannot produce a normal DH response to these antigens afterdesensitization. The mecha-
nism involved clearly effects DH responses to PPD transiently, however, they remain
susceptible to repeated re-establishment of the desensitized state.
were immunizedwith BGGin CFA on day 18 after the initial immunization and
then desensitized with BGGfrom day 25, DH skin unresponsiveness toPPD was
rapidly reinstated. InjectionsofBGG maintained this lack ofDH tothe indiffer-
ent antigen for 10 days; the cycle was repeated again by immunizing and
subsequently desensitizing with OA. InFig. 2, the meanvalues for thediameter
ofthe induration induced by DH testing are given and the oscillations in PPD
responses are clearly illustrated. This experiment demonstrates that(a) there is
no exhaustion of the mechanism needed for preventing a DH response to the
indifferent antigen; and (b) desensitization is again shown to depend upon
sensitization.
Passive Transfer ofDH using Lymphocytes from Short-Term or Long-Term
Desensitized Guinea Pigs .
￿
Six guinea pigs immunized with HSA and BGG in594
CFA were desensitized for 3 or 7 days before the transfer ofperitoneal exudate
cells to normal recipients. Two guinea pigs were required for sufficient cells for
one transfer. Similarly, cells were transferred from 6 animals immunized 55
days before transfer and 6 similarly immunized animals who had been desensi-
tized with HSA for 38 days before transfer, and with BGG for 29 days before
transfer. In all, cells from 24 animals were transferred to 12 normal recipients.
These animals were skin tested immediately after receiving the cells. Table III
shows that cells from short-term desensitized animals and long-term immunized
animals adequately transferred DH to normal animals. However, cells from
long-term desensitized animals, while capable oftransferring responsiveness to
PPD (the indifferent antigen) which had escaped from the desensitizing influ-
ence, could not transfer DH to HSA and BGG (both desensitizing antigens) a
finding that further strengthens the concept that true immunological tolerance
to these antigens had been induced.
Effect of Transferring Spleen Cells from Long-Term Desensitized Animals to
Immunized Recipients . The spleens from the long-term desensitized Hartley
guinea pigs detailed in Table I were larger than spleens from long-term immu-
nized animals used as controls (mean, 520 mg ± 80 SD for control animals and
830 mg ± 95 SD for desensitized animals). The spleen appears to be an excellent
source of suppressor T cells (7) and we sought evidence for such activity in the
large spleens. Eight inbred strain 2 guinea pigs were immunized with HSA and
TABLE III
Comparison of the Ability of PE Cells to Passively Transfer DH after Short- or Long-
Term Desensitization
Status of guinea pig donors*
SUPPRESSION OF DELAYED HYPERSENSITIVITY
Pooled
group no.
Mean diameter of DH skin reactions in:
Donors
￿
Recipients
* Allguinea pigs were immunizedwith HSAin CFA. Animalsin groups 1-6were immunizedwith
BGGandHSA simultaneously; for animalsin groups 7-12, BGGimmunization followed HSA by
17 days. Desensitization commenced7 days afterimmunization.
HSA
MM
BGG
mm
PPD
mm
HSA
mm
BGG
mm
PPD
mm
Desensitized for 3 days before 1 5.5 7.0 6.5 7.5 7.5 5.0
transfer with HSAand BGG 2 4.0 7.0 7.5 8.5 8.5 7.0
3 3.0 6.5 8.5 5.5 7.5 5.5
Desensitized for 7 days before 4 5.0 10.0 7.5 9.5 0 8.5
transfer with HSAandBGG 5 3.0 8.5 6.0 7.5 9.0 8.0
6 3.0 7.5 8.0 8.5 8.5 7.5
Immunized 55 days earlier 7 30.0 28.0 14.0 9.0 13 .5 8.5
8 27.0 26.0 11.5 14.0 8.0 8.0
9 25.0 18.0 15.5 12.5 9.5 8.0
Desensitized with HSA for 38 10 4.0 2.0 17.0 0 0 11.5
days and BGG for 29 days be- 11 3.0 5.0 11.5 0 0 7.5
fore transfer 12 5.0 4.0 9.5 0 0 7.0d. M. DWYER AND F. S. KANTOR
￿
595
BGG in CFA and were desensitized for at least 25 days with HSA and BGG. 15
days before cell transfer, these animals were immunized with OA in CFA and
desensitized with OA for the 7 days before transfer. DH to PPD was still
suppressed by this regimen when spleen cells were harvested. Eight strain 2
recipients were prepared for cell transfer by immunization with Pic-GPA in
CFA 3 wk before transfer. Four of these animals received pooled cells from the
spleen of two of the desensitized donors. No suppressive effect of spleen cells
from desensitized donors was observed in this system as DH responses to Pic-
GPA were equivalent in the control and recipient groups . The mean diameter
(millimeters) ± SD of DH responses to PPD and Pic-GPA were, respectively,
13 .5 ± 3.7 and 24.5 ± 6.4 for the control group, and 14.0 ± 4.5 and 22.5 ± 7.4 for
the group given cells from desensitized animals.
Passive Transfer of DH after Exposure of Sensitized Cells to Serum from
Desensitized Animals. A series of experiments were designed to look for a
humoral suppressant ofDH in the serum from desensitized guinea pigs. In each,
the desensitized serum was collected from animals known to have good general-
ized suppression of DH reactivity. Passive transfer of DH to normal animals was
attempted with sensitized lymphocytes cultured in serum from desensitized
animals. In another approach the effect on DH of an intravenous injection of this
serum into immunized animals was examined. 18 guinea pigs were immunized
with HSA and BGG in CFA and skin tested 3-4 wk later . A similar number of
animals were immunized with HSA and BGG in CFA but were desensitized on
the 7th and 8th days afterimmunization; i.e., the 2 days before cell harvesting.
Peritoneal exudate cells were harvested from both groups and put into tissue
culture for 16 h. For half of the cell samples, the culture media was constituted
with 30% serum from desensitized animals. These short-term cultured cells were
then transferred into four groups offour normal guinea pigs. One group received
PE cells from immunized animals ; a second, PE cells from immunized animals
cultured in the serum from desensitized animals; a third, cells from desensitized
animals ; and a fourth, cells from desensitized animals cultured in serum from
desensitized animals. Exposure to the serum from desensitized guinea pigs
could not be shown to interfere with DH transfer. In addition, eight guinea pigs
immunized with HSA and BGG in CFA 3 wk earlier each received a 3 ml
intravenous injection of the serum from desensitized animals and were then
tested for DH to HSA, BGG, and PPD. No suppression of DH occurred.
Effect on DH of Injecting Serum from Desensitized Animals Directly into
Skin Challenge Sites. 12 guinea pigs were immunized with Pic-GPA and HSA
in CFA. 3 wk later all were skin tested with Pic-GPA, HSA, and CFA. Four
animals were skin tested with a standard dose of antigen but into one flank the
antigens were administered with serum from desensitized animals. Four ani-
mals were similarly tested except that half the normal skin test dose was used.
A final group of four guinea pigs had desensitized serum injected into three skin
sites on one flank 3 h before antigen was given into the same sites. In each case,
DH responsiveness on both flanks were comparable, the serum from desensi-
tized animals having no apparent effect.
Effect of Serum from Desensitized Guinea Pigs on In Vitro Responses of
Cultured Cells to PHA.
￿
Dose response curves of the response of lymphocytes to596
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PHA stimulation in either commercial guinea pig sera or sera from desensitized
animals were constructed. PHA stimulationoflymphocytesfrom normal, immu-
nized, and desensitized guinea pigs were compared in both types of sera; no
effect of the desensitized serum was observed nor were the cells from desensi-
tized animals inferior intheir response to PHA. Control values for unstimulated
cultures ranged between 279 and 602 cpm.
Effect of Serum from Desensitized Animals on the In Vitro Response of
Lymphocytes to PPD. Canserafrom guinea pigs in whomtheexpression ofDH
to PPD has been markedly suppressed by injection of HSA and BGG similarly
effect the in vitro response ofcells to PPD? 14 guinea pigs were immunized with
HSA, BGG, and OA in CFA; 16 were similarly immunized but desensitized for
the 2 days before cell culture, and 4 normal human subjects known to have
strongly positive DH to tuberculin were bled and their peripheral blood lympho-
cytes stimulated with PPD in media containing serum from either normal,
immunized, or desensitized guinea pigs. To be sure the lymphocytes were
capable ofresponse, PHA stimulation was performed simultaneously. As can be
seen in Table IV, all cells responded well to PHA in any serum. However, both
the sera from immunized and desensitized animals markedly reduced the cellu-
lar response to PPD. Certainly no suppression related to the desensitized state
could be claimed. Guinea pig control counts from unstimulated controls ranged
from 280 cpm to 497 cpm for PHA and from 480 cpm to 720 cpm for PPD.
Unstimulated human cells had background counts of 376-674 cpm for PHA
cultures, and 590-870 cpm for PPD cultures.
TABLE IV
Effect of Serumfrom Desensitized Guinea Pigs on In Vitro Response ofLymphocytes to
PPD
Noof .
DNA synthesis in stimulated lymphocytes
expressed as a mean stimulation index*
berculin sensitivity
* Actual counts per minutes and range are included in test.
t Normal guinea pigserumused forguinea pigcells, normal pooled humanserumforhumancells.
§ Immunized with HSA, BGG, and OA in CFA 10 days before culture.
11 Immunizedto HSA, BGG, OA, andPPD and desensitized with HSA and BGG 2days before cell
culture.
Source of cultured cells donors Serum from Serum from
Normal serumt immunized desensitized studied
PHA PPD
guinea
PHA
pigs
PPD
guinea
PHA
pigs
PPD
Guinea pigs immunized 14 21 18 18 3.4 20 3.5
with PPD§
Guinea pigs immunized 16 18 15 11 4 17 6
with PPD but desensi-
tized11
Humans with positive tu- 4 83 54 42 13 47 6J. M. DWYER AND F. S. KANTOR
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Discussion
Since its discovery in 1958 (3), desensitization has remained a poorly under-
stood phenomenon. Administration of moderate amounts of an antigen to an
immunized animal leads to a transient (3 days with one injection) loss of DH
reactivity (2). Desensitization can be induced in species other than guinea pigs
(8) and has been considered to affect cellularrather than humoral immunity (9).
Itis not associated with alackofavailablemacrophages, the target cells ina DH
response (1), nor is it due to exhaustion of antigen. Lymphocytes capable of
specifically reacting to antigen with lymphokine release are present in the
desensitized state (1). We have previously suggested that DH reactions may be
terminated by a feedback inhibition factor (FIF) which would act as a nonspe-
cific terminatorofDH (4). Desensitization may represent an exaggeration ofthis
normal mechanism induced by an intensive reaction between sensitized cells
and large amounts of antigen resulting in a systemic effect. The fact that
immunocompetent cells transferred into desensitized animals lose that compe-
tence and that immunocompetent cells regain their competence once removed
from desensitized animals is consistent with an active suppressive state (3).
The evidence presented herein supports the concept that the onset ofdesensiti-
zation is associated with the triggering ofan inhibitory regulator for DH rather
than the exhausting ofa required cellular mediator. Once immunological toler-
ance is established to the desensitizing antigen, generalized anergy disappears.
It is clear that cells sensitized to the indifferent antigens do not lose their
responsiveness to the desensitizing mechanism as they respond repeatedly to
new desensitizing regimens .
An hypothesis to explain desensitization would have antigen interacting both
with sensitized effector cells and a subpopulation of suppressor T cells suscepti-
ble to exaggerated triggering by the desensitizing injections. Such suppressor
cells would reduce ordinary reactivity of effector T cells either by cell to cell
interaction, or by the release of a humoral factor (FIF) that in turn would
interfere with the development ofa DH response. The spleen ofthe mouse has
been shown to contain much of the suppressor T-cell population (7). It seemed
likely that cells from this organ in long-term desensitized animals would have
some suppressive effect on DH in immunized animals receiving these cells. In
our experiment, this was not so despite the enlargement of the spleen in
desensitized animals. This may have been due to the fact that nonspecific
anergy, although present in the donor animals, was beginning to wane. If
nonspecific desensitization in guinea pigs could be prolonged, it would make an
attractivemodel for thenonspecific anergic state seen with human diseases such
as leprosy (10) and sarcoidosis (11, 12). It should be possible to reduce the dose of
desensitizing antigen to a level that prevents tolerance induction, but prelimi-
nary experiments have pointed out the difficulty of doing this due to the
development ofimmediate hypersensitivity reactions with the lower doses.
A humoral factor which can inhibit lymphocyte responsiveness has been
reported in syphilis (13), sarcoidosis (14), mucocutaneous candidiasis (15), and
leprosy (10). Thus, we were anxious to see ifserum from adequately desensitized
animals was immunosuppressive. We found no supportive evidence for such a
factor, and although none of our experiments eliminated this possibility, it is598
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clear that if such a factor is present it is difficult to demonstrate. Our in vitro
studies established that cells from desensitized animals can respond normally to
PHA and antigens in culture and can transfer DH to normal animals after a
night in culture. The ability of these cells and cells from immunized but not
desensitized hosts to transfer DH is not reduced by a 16 h exposure to 30% serum
from desensitized animals. An injection of 3 ml of this serum into immunized
animals does not reduce their capacity for DH responsiveness. Perhaps this is a
suboptimal dose but it is the maximum that can be given intravenously in a
single injection to guinea pigs. The fact that serum from animals immunized as
well as desensitized to PPD reduces the ability of cells sensitized to PPD to
respond to that antigen in culture suggests that a blocking antibody mechanism
may be responsible. This blocking factor makes it impossible to dissect the
immunized from the desensitized state in our current system. A more definitive
experiment to search for a desensitization factor that can nonspecifically block
antigen stimulation of cells in tissue culture would use serum from animals
immunized and desensitized with antigens that had not been administered to
the donors of the cells used for stimulation with antigen. We are pursuing this
approach . Our experiments demonstrate desensitization to be an actively pro-
duced phenomenon and leave intact the hypotheses that a suppressor cell
mechanism is responsible .
Summary
Administering moderate (milligram) amounts of antigen to a guinea pig
immunized with that antigen leads to a transient loss of all delayed hypersensi-
tivity (DH) responses in that animal. In this study, we demonstrate that this
"desensitization" can be prolonged for 10 days by repeated injection of antigen.
At this time, tolerance to the desensitizing antigen develops in both the humoral
and cellular systems of the immune response and DH responsiveness to other
antigens returns. Repeated cycles of sensitization and desensitization produce
repeated episodes of generalized anergy. Neither cells nor serum from desensi-
tized animals could be shown to exert a suppressor effect when transferred to
immunized animals and the cells responded normally to antigen and mitogen in
tissue culture. The best generalized depression of DH was seen in those animals
producing the best DH before desensitization. The inability of antigen to react
with tolerant cells to produce desensitization suggests that this phenomenon is
an active rather than a passive one and may represent an exaggeration of a
normal regulatory mechanism for DH triggered by a regimen of antigen admin-
istration that activates suppressor cells to produce a systemic effect.
Received for publication 3 April 1975 .
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